These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2587049)

  • 1. Severe retinal vaso-occlusive disease secondary to procainamide-induced lupus.
    Nichols CJ; Mieler WF
    Ophthalmology; 1989 Oct; 96(10):1535-40. PubMed ID: 2587049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scleritis as the presenting manifestation of procainamide-induced lupus.
    Turgeon PW; Slamovits TL
    Ophthalmology; 1989 Jan; 96(1):68-71. PubMed ID: 2645552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Severe occlusive bilateral retinal vasculitis within the scope of seronegative systemic lupus erythematosus].
    Koch JW; al Nawaiseh I; Koch FH
    Klin Monbl Augenheilkd; 1992 Nov; 201(5):330-6. PubMed ID: 1479791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylprocainamide therapy in patients with previous procainamide-induced lupus syndrome.
    Kluger J; Drayer DE; Reidenberg MM; Lahita R
    Ann Intern Med; 1981 Jul; 95(1):18-23. PubMed ID: 6166229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe retinal vaso-occlusive disease in systemic lupus erythematous.
    Jabs DA; Fine SL; Hochberg MC; Newman SA; Heiner GG; Stevens MB
    Arch Ophthalmol; 1986 Apr; 104(4):558-63. PubMed ID: 3954661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary retinal vasculitis. Systemic associations and diagnostic evaluation.
    George RK; Walton RC; Whitcup SM; Nussenblatt RB
    Ophthalmology; 1996 Mar; 103(3):384-9. PubMed ID: 8600413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe vaso-occlusive retinopathy as the primary manifestation in a patient with systemic lupus erythematosus.
    Ho TY; Chung YM; Lee AF; Tsai CY
    J Chin Med Assoc; 2008 Jul; 71(7):377-80. PubMed ID: 18653404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin immunofluorescence studies on lupus erythematosus and other antinuclear-antibody-positive diseases.
    Grossman J; Callerame ML; Condemi JJ
    Ann Intern Med; 1974 Apr; 80(4):496-500. PubMed ID: 4621260
    [No Abstract]   [Full Text] [Related]  

  • 9. Polyglandular autoimmune endocrinopathy following procainamide induced lupus.
    Finger DR; Bernet VJ; Doyle JJ
    J Rheumatol; 1995 Mar; 22(3):574-5. PubMed ID: 7783091
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunologic tests: Anti-histone antibodies].
    Suwa A
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():464-6. PubMed ID: 16111302
    [No Abstract]   [Full Text] [Related]  

  • 11. A systemic lupus erythematosus-like syndrome induced by procainamide.
    Zeide MS; Wiesel S; Terry R; Stein D
    Clin Orthop Relat Res; 1978; (134):290-2. PubMed ID: 729256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serologic evaluation of patients receiving procainamide.
    Mongey AB; Donovan-Brand R; Thomas TJ; Adams LE; Hess EV
    Arthritis Rheum; 1992 Feb; 35(2):219-23. PubMed ID: 1734911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procainamide induced lupus erythematosus syndrome.
    Sanford HS; Michaelson AK; Halpern MM
    Dis Chest; 1967 Feb; 51(2):172-6. PubMed ID: 6019120
    [No Abstract]   [Full Text] [Related]  

  • 14. SLE: idiopathic or drug-induced?
    Condemi JJ
    Geriatrics; 1980 Mar; 35(3):81-8. PubMed ID: 6965485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous bilateral purtscher like retinopathy with systemic lupus erythematosus: a case.
    Wang X; Bao L
    BMC Ophthalmol; 2024 Sep; 24(1):418. PubMed ID: 39333945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crithidia luciliae assay for antibodies to native DNA in procainamide-induced lupus erythematosus.
    Dixon JA; Mulhern LM; Whiteside TL; Luksick J
    J Rheumatol; 1980; 7(4):544-6. PubMed ID: 6999152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinuclear antibodies as indicators for the procainamide-induced systemic lupus erythematosus-like syndrome and its clinical presentations.
    Gorsulowsky DC; Bank PW; Goldberg AD; Lee TG; Heinzerling RH; Burnham TK
    J Am Acad Dermatol; 1985 Feb; 12(2 Pt 1):245-53. PubMed ID: 3882781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy).
    Kleiner RC; Najarian LV; Schatten S; Jabs DA; Patz A; Kaplan HJ
    Ophthalmology; 1989 Jun; 96(6):896-904. PubMed ID: 2472589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual recovery and vascular reperfusion after vaso-occlusive retinopathy from anti-phospholipid syndrome associated with systemic lupus erythematosus.
    Deaner JD; Zeft AS; Emami-Naeini P; Lowder CY
    Am J Ophthalmol Case Rep; 2020 Sep; 19():100763. PubMed ID: 32551401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agranulocytosis caused by procainamide.
    Hickson B; Davidson RJ; Walker W
    Scott Med J; 1972 May; 17(5):165-8. PubMed ID: 4537437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.